News
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.
While most people associate Alzheimer's symptoms with old age, new research suggests signs could begin to show up in your 20s ...
Journalist and women’s health advocate Maria Shriver discusses an important new advance in the fight against Alzheimer’s ...
A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...
Cognitive reserve is the mind’s resistance to damage the brain.
MIT and Harvard scientists have discovered potential new targets for treating or preventing Alzheimer's disease.
By combining information from many large datasets, MIT researchers have identified several new potential targets for treating ...
People living with dementia and long-term care residents should be part of disaster preparedness efforts, the Alzheimer’s ...
Researchers are exploring how sleep, diet, and activity may fuel inflammation and lead to Alzheimer’s disease in women.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback